| 2026-05-07 |
详情>>
内部人交易：
Conklin James股份增加22872.00股
|
| 2026-05-06 |
详情>>
股本变动：
变动后总股本7841.34万股
|
| 2026-05-06 |
详情>>
业绩披露：
2026年中报每股收益0.06美元,归母净利润500.00万美元,同比去年增长101.49%
|
| 2026-05-06 |
财报披露：
美东时间 2026-05-06 盘前发布财报
|
| 2026-01-21 |
股东大会：
将于2026-03-10召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following eight directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2027;
2.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2026 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3.To approve, on an advisory basis, our named executive officer compensation, as described in the accompanying Proxy Statement;
4.To renew the Board of Directors’ authority to issue shares under Irish law;
5.To renew the Board of Directors’ authority to opt-out of statutory preemption rights under Irish law;
6.To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2025, and the reports of the directors and auditors thereon, and to review the affairs of Adient;
7.To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|
| 2025-11-18 |
详情>>
业绩披露：
2025年年报每股收益-3.39美元,归母净利润-2.81亿美元,同比去年增长-1661.11%
|
| 2025-11-18 |
详情>>
业绩披露：
2023年年报每股收益2.17美元,归母净利润2.05亿美元,同比去年增长270.83%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-3.56美元,归母净利润-2.99亿美元,同比去年增长-390.16%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年中报每股收益-3.98美元,归母净利润-3.35亿美元,同比去年增长-570%
|
| 2025-01-28 |
详情>>
业绩披露：
2025年一季报每股收益0.00美元,归母净利润0.00美元,同比去年增长-100%
|
| 2025-01-22 |
股东大会：
将于2025-03-11召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following eight directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2026:
2.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2025 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3.To approve, on an advisory basis, our named executive officer compensation, as described in the accompanying Proxy Statement;
4.To approve the adoption of Adient’s 2021 Omnibus Incentive plan as amended and restated;
5.To renew the Board of Directors’ authority to issue shares under Irish law;
6.To renew the Board of Directors’ authority to opt-out of statutory preemption rights under Irish law;
7.To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2024, and the reports of the directors and auditors thereon, and to review the affairs of Adient;
8.To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|
| 2024-11-18 |
详情>>
业绩披露：
2024年年报每股收益0.20美元,归母净利润1800.00万美元,同比去年增长-91.22%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.67美元,归母净利润-6100万美元,同比去年增长-187.14%
|
| 2024-05-03 |
详情>>
业绩披露：
2024年中报每股收益-0.55美元,归母净利润-5000万美元,同比去年增长-1566.67%
|
| 2024-01-23 |
股东大会：
将于2024-03-12召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following nine directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2025:
Julie L. Bushman, Jerome J. Dorlack, José M. Gutiérrez, Peter H. Carlin, Jodi E. Eddy, Frederick A. Henderson, Ricky T. Dillon, Richard Goodman, Barb J. Samardzich
2.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2024 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3.To approve, on an advisory basis, our named executive officer compensation, as described in the accompanying Proxy Statement;
4.To renew the Board of Directors’ authority to issue shares under Irish law;
5.To renew the Board of Directors’ authority to opt-out of statutory preemption rights under Irish law;
6.To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2023, and the reports of the directors and auditors thereon, and to review the affairs of Adient;
7.To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|
| 2023-01-24 |
股东大会：
将于2023-03-07召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following eight directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2024:Julie L. Bushman,Ricky T. Dillon,Frederick A. Henderson,Peter H. Carlin,Richard Goodman,Barb J. Samardzich,Douglas G. Del Grosso,Jose M. Gutierrez
2.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2023 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3.To approve, on an advisory basis, our named executive officer compensation, as described in the accompanying Proxy Statement;
4.To approve, on an advisory basis, the frequency of future advisory votes on named executive officer compensation;
5.To renew the Board of Directors’ authority to issue shares under Irish law;
6.To renew the Board of Directors’ authority to opt-out of statutory preemption rights under Irish law;
7.To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2022, and the reports of the directors and auditors thereon, and to review the affairs of Adient;
8.To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|
| 2022-01-25 |
股东大会：
将于2022-03-08召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following nine directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2023:
2.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2022 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3.To approve, on an advisory basis, our named executive officer compensation, as described in the accompanying Proxy Statement;
4.To renew the Board of Directors’ authority to issue shares under Irish law;
5.To renew the Board of Directors’ authority to opt-out of statutory preemption rights under Irish law;
6.To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2021 and the reports of the directors and auditors thereon and to review the affairs of Adient;
7.To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-01-26 |
股东大会：
将于2021-03-09召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following eight directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2022
2.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2021 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3.To approve, on an advisory basis, our named executive officer compensation, as described in the accompanying Proxy Statement;
4.To approve the adoption of Adient’s 2021 Omnibus Incentive Plan;
5.To renew the Board of Directors’ authority to issue shares under Irish law;
6.To renew the Board of Directors’ authority to opt-out of statutory preemption rights under Irish law;
7.To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2020 and the reports of the directors and auditors thereon and to review the affairs of Adient;
8.To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|
| 2020-01-28 |
股东大会：
将于2020-03-12召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following eight directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2021: Julie L. Bushman, Douglas G. Del Grosso, Frederick A. Henderson, Peter H. Carlin, Richard Goodman, Barb J. Samardzich, Raymond L. Conner, Jose M. Gutierrez.
2.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2020 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3.To approve, on an advisory basis, our named executive officer compensation, as described in the accompanying Proxy Statement;
4.To approve the adoption of Adient’s Amended and Restated Director Share Plan;
5.To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2019 and the reports of the directors and auditors thereon and to review the affairs of Adient;
6.To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|
| 2019-01-25 |
股东大会：
将于2019-03-11召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following eight directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2020:
John M. Barth
Raymond L. Conner
Frederick A. Henderson
Julie L. Bushman
Douglas G. Del Grosso
Barb J. Samardzich
Peter H. Carlin
Richard Goodman
2.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2019 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3.To approve, on an advisory basis, our named executive officer compensation, as described in the accompanying Proxy Statement;
4.To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2018 and the reports of the directors and auditors thereon and to review the affairs of Adient;
5.To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|
| 2018-10-10 |
除权日：
美东时间 2018-10-23 每股派息0.28美元
|
| 2018-06-05 |
除权日：
美东时间 2018-07-17 每股派息0.28美元
|
| 2018-03-12 |
除权日：
美东时间 2018-04-17 每股派息0.28美元
|
| 2018-01-26 |
股东大会：
将于2018-03-12召开股东大会
会议内容 ▼▲
- 1. To elect, by separate resolutions, the following seven directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2019:
John M. Barth Richard Goodman Barb J. Samardzich
Julie L. Bushman Frederick A. Henderson
Raymond L. Conner R. Bruce McDonald
2. To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2018 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3. To approve, on an advisory basis, our named executive officer compensation;
4. To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2017 and the reports of the directors and auditors thereon and to review the affairs of Adient;
5. To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|
| 2017-11-07 |
除权日：
美东时间 2018-01-17 每股派息0.28美元
|
| 2017-09-12 |
除权日：
美东时间 2017-10-17 每股派息0.28美元
|
| 2017-07-12 |
除权日：
美东时间 2017-07-24 每股派息0.28美元
|
| 2017-03-13 |
除权日：
美东时间 2017-03-24 每股派息0.28美元
|
| 2017-01-23 |
股东大会：
将于2017-03-13召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following seven directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2018:
John M. Barth Frederick A. Henderson
Julie L. Bushman R. Bruce McDonald
Raymond L. Conner Barb J. Samardzich
Richard Goodman
2.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as our independent auditor for fiscal year 2017 and to authorize, by binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors’ remuneration;
3.To approve, on an advisory basis, our named executive officer compensation;
4.To consider an advisory vote on the frequency of the advisory vote on named executive officer compensation;
5.To approve the material terms of the performance goals under Adient’s 2016 Omnibus Incentive Plan;
6.To receive and consider Adient’s Irish Statutory Accounts for the fiscal year ended September 30, 2016 and the reports of the directors and auditors thereon and to review the affairs of Adient;
7.To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.
|